PURPOSE: The Thoratec Implantable Ventricular Assist Device (IVAD™) is the only FDA-approved intracorporeal biventricular cardiac assist device. It is a titanium-coated version of its predecessor, the Paracorporeal Ventricular Assist Device (PVAD™).

THORATEC I'ARACORPOREIIL PNEl MATIC VAD 355 Fig IV. Artist's rendition of a cut-a-way of the prosthetic ventricle with a rigid polycarbonate housing enclosing a seam-free proprietary segmented polyurethane sac. Monostrut inlet and outlet valves provide unidirectional flow when pulses of air are delivered between the outer

The Thoratec ventricular assist device (VAD) (Thoratec Corporation, Pleasanton, CA) has been extensively used as the standard therapy for bridge-to-transplant and postcardiotomy failure to wean from cardiopulmonary bypass. 1 Recent clinical data suggest that myocardial recovery and improved cardiac function occur in some patients over a period ...

The Thoratec PVAD is a pneumatically driven, pulsatile, and paracorporeal VAD that can be used to assist both the ventricles (LVAD, RVAD, and biventricular VAD (BiVAD)). Thoratec PVAD has been used for short-term and long-term support.

Thoratec Corporation is a United States–based company that develops, manufactures, and markets proprietary medical devices used for mechanical circulatory support for the treatment of heart-failure patients worldwide. It is a global leader in mechanical circulatory support devices, particularly in ventricular assist devices (VADs). [3] [4]For …

The Thoratec Ventricular Assist Device (VAD) System (Thoratec Laboratories, Pleasanton, CA) is a paracorporeal pump that can provide univentricular or biventricular assistance for patients with heart failure.

Background: The Thoratec Implantable Ventricular Assist Device (IVAD) is the only FDA-approved intracorporeal biventricular cardiac assist device. It is a titanium-coated version of its predecessor, the Paracorporeal Ventricular Assist Device (PVAD).

With more than 20 years of clinical use, the PVAD can support a wide range of patients with advanced heart failure. The device is approved in the U.S. for Bridge-to-Transplantation (BTT) and Post-Cardiotomy Recovery from open-heart surgery.

When used with the tlc-ii portable pneumatic driver, the pvad is intended for use for transportation of vad patients via ground ambulance, fixed wing aircraft or helicopter.

Monostrut inlet and outlet valves provide unidirectional flow when pulses of air are delivered between the outer case and the stroke-limiting diaphragm.